Last updated: 07/28/2020 13:10:17

ADCARE: ADherence to treatment in COPD and Asthma: a REpresentative observational, multicentre, cross-sectional study in adults

GSK study ID
200368
Clinicaltrials.gov ID
Not applicable
EudraCT ID
Not applicable
EU CT Number
Not applicable
Trial status
Study complete
Study complete
Overview
Eligibility
Locations
Study documents
Results summary
Plain language summaries
Additional information

Trial overview

Official title: ADCARE: ADherence to treatment in COPD and Asthma: a REpresentative observational, multicentre, cross-sectional study in adults
Trial description: ADCARE: ADherence to treatment in COPD and Asthma: a REpresentative observational, multicentre, cross-sectional study in adults
Primary purpose:
Not applicable
Trial design:
Not applicable
Masking:
Not applicable
Allocation:
Not applicable
Primary outcomes:
Not applicable
Secondary outcomes:
Not applicable
Interventions:
Not applicable
Enrollment:
Not applicable
Primary completion date:
2017-03-01
Observational study model:
Not applicable
Time perspective:
Not applicable
Clinical publications:
Nurdan Kokturk, Mehmet Polatli, I. Kivilcim Oguzulgen, Sarfraz Saleemi, Mohammed Al Ghobain, Javed Khan, Adam Doble, Luqman Tariq, Fayaz Aziz, Abdelkader El Hasnaoui. Adherence to COPD Treatment in Turkey and Saudi Arabia: Results of the ADCARE study. Int J Chron Obstruct Pulmon Dis. 2018;13:1377-1388. DOI: 10.2147/COPD.S150411
Medical condition
Pulmonary Disease, Chronic Obstructive
Product
fluticasone propionate, fluticasone propionate/salmeterol, salmeterol
Collaborators
Not applicable
Study date(s)
May 2015 to January 2017
Type
Observational
Phase
4

Participation criteria

Sex
Not applicable
Age
Not applicable
Accepts healthy volunteers
Not applicable

Trial location(s)

Location
Status
Contact us
Contact us
Location
GSK Investigational Site
Ankara, Turkey, 06100
Status
Study Complete
Location
GSK Investigational Site
Ankara, Turkey, 06280
Status
Study Complete
Location
GSK Investigational Site
Ankara, Turkey, 06490
Status
Study Complete
Location
GSK Investigational Site
Antalya, Turkey, 07400
Status
Study Complete
Location
GSK Investigational Site
Aydin, Turkey, 09010
Status
Study Complete
Location
GSK Investigational Site
Bartin, Turkey
Status
Study Complete
Showing 1 - 6 of 24 Results

Study documents

No study documents available.

Results overview

No study documents available

Recruitment status
Study complete
Actual primary completion date
2017-03-01
Actual study completion date
2017-03-01

Plain language summaries

Not applicable. GSK’s transparency policy provides for Plain Language Summaries for Interventional studies.

Additional information about the trial

Not applicable
Participate in clinical trial
Access to clinical trial data by researchers
Visit website